Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Vaccines|December 23, 2023
Epidemiology of Meningococcal Disease in Four South American Countries and Rationale of Vaccination in Adolescents from the Region: Position Paper of the Latin American Society of Pediatric Infectious Diseases (SLIPE)Rodolfo Villena, Marco Aurelio Safadi, Ángela Gentile, et al.
Revista Panamericana De Salud Publica = Pan American Journal of Public Health|May 17, 2019
[Impact of the 10-valent pneumococcal conjugate vaccine on the southern area of Santiago (Chile), 2009-2015Efeito da vacina pneumocócica 10-valente conjugada na região sul de Santiago, Chile, 2009-2015]Sylvina Alvarado, Gabriel Cavada, Rodolfo Villena, et al.
Vaccines|September 27, 2025
Need for Invasive Meningococcal Disease Prevention Through Vaccination for Young Children in the AmericasGaurav Mathur, Joseph B Domachowske, Maria Gabriela Graña, et al.
Vaccines|November 26, 2025
Invasive Meningococcal Disease in the Post-COVID-19 Era in South AmericaMarco A P Sáfadi, Juan Francisco Falconi, Maria Gabriela Abalos, et al.
The Pediatric Infectious Disease Journal|June 2, 2023
Hypervirulent Strains of Neisseria meningitidis and Clinical Manifestations in Children With Invasive Meningococcal DiseaseMaría Carolina Rivacoba, Rodolfo Villena, Juan Carlos Hormazabal, et al.
Revista Chilena De Pediatria|August 24, 2015
[Seroconversion in response to a reinforced primary hepatitis B vaccination in children with cancer]Rodolfo Villena, Marcela Zubieta, Carmen Hurtado, et al.
The Pediatric Infectious Disease Journal|June 3, 2016
Rotavirus Serum IgA Immune Response in Children Receiving Rotarix Coadministered With bOPV or IPVSasirekha Ramani, Nora Mamani, Rodolfo Villena, et al.
The Lancet. Infectious Diseases|August 31, 2015
Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority studyMiguel O'Ryan, Ananda S Bandyopadhyay, Rodolfo Villena, et al.
Vaccines|October 28, 2023
Different Safety Pattern of an Inactivated SARS-CoV-2 Vaccine (CoronaVac<sup>®</sup>) According to Age Group in a Pediatric Population from 3 to 17 Years Old, in an Open-Label Study in ChileNicole Le Corre, Katia Abarca, Patricio Astudillo, et al.
Mbio|November 16, 2022
Inactivated Vaccine-Induced SARS-CoV-2 Variant-Specific Immunity in ChildrenJorge A Soto, Felipe Melo-González, Cristián Gutierrez-Vera, et al.
Pageof 3